Category list : Anti-asthmatic agents
Sort by: Newest first Oldest first A-Z Z-A
-
NICE recommends first asthma treatment to target eosinophils
Mepolizumab has been recommended as an add-on injectable treatment for severe refractory eosinophilic asthma in adults.
-
Long-acting beta-agonist combination therapy not linked with serious asthma events Subscription
A study of asthma patients found that the combination treatment budesonide/formoterol and budesonide alone produced a similar number of serious asthma-related events.
-
Vitamin D reduces the rate of severe asthma attacks
Vitamin D supplementation can reduce the risk of severe asthma attacks by over a third, a systematic review has found.
-
Why we need write access to patient summary care records Subscription
A patient came into our pharmacy requesting an emergency supply of a salbutamol inhaler recently. He lives elsewhere but was working locally. We accessed his summary care record (SCR) and, to our surprise, discovered that he had not been prescribed anything since 2015. Before then, he was regularly prescribed beclomethasone and salbutamol inhalers. In addition, the surgery details he provided were incorrect.
-
Injectable asthma drug reslizumab approved by European Commission
The European Commission has approved a marketing authorisation for reslizumab (Teva Pharmaceutical Industries’ Cinqaero), an injectable treatment for use in severe asthma.
-
Lung disease patients still don’t use inhalers properly
Data spanning 40 years show only 31% of patients with asthma or COPD use inhalers correctly, prompting calls for new approaches to education and drug delivery.
-
Oral treatment shows promise for persistent eosinophilic asthma
An early trial of the experimental oral asthma therapy fevipiprant has shown it is effective in reducing airway inflammation among patients with persistent eosinophilic asthma.
-
How to help patients optimise their inhaler technique Subscription
Examining the impact of sub-optimal inhaler technique and how healthcare professionals can support patients in optimising their technique.
-
Impact of a pharmacist-led asthma and COPD respiratory clinic in general practice Subscription
Asthma and chronic obstructive pulmonary disease (COPD) continue to account for a large burden of disease in the UK. Despite comprehensive guidelines, more than 1,000 people die from asthma each year and COPD accounts for a leading cause of emergency admissions in the UK. In a joint initiative between NHS City and Hackney clinical commissioning group and the local tertiary centre for respiratory disease Barts Health NHS Trust, asthma and COPD reviews were undertaken by a specialist ...
-
We need more investment in diagnostics for asthma Subscription
Recent headlines in national media have declared that asthma is ‘overdiagnosed and trivialised’. But as I am sure your readers know, these news stories are masking a deeper issue: there is no simple diagnostic test for asthma. It is shocking that in the 21st century we still do not have a simple test to be able to tell if someone has asthma, a condition so ...
Show 10 per page20 per page50 per page
